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Abstract 
Neuroplasticity refers to the brain’s ability to change with experience. Continuous 
theta burst stimulation (cTBS) is a non-invasive brain stimulation technique capable of 
temporarily inducing neuroplasticity in the primary motor cortex (M1), as indicated by 
changes in the excitability of the stimulated brain region. However, cTBS-induced 
neuroplasticity shows large inter-individual variability, which limits its potential in 
research and clinical settings. The present study investigated whether down-regulating 
motor cortical inhibition, with cTBS applied using a lower than conventional intensity 
(cTBSlow), is capable of making the brain more amenable to the neuroplasticity-
inducing effects of cTBS applied using the conventional intensity. Thirty-two, right-
handed, healthy adults participated in two experimental sessions: 1) cTBS primed by 
cTBSlow; 2) cTBS primed by sham stimulation. Due to unforeseen technical issues, 
there were two groups: group 1 received cTBSlow with conventional bursts; group 2 
received cTBSlow with reduced pulses per burst. Motor cortical excitability and 
inhibition were measured from an intrinsic hand muscle at baseline, between the two 
cTBS applications, and following cTBS. In group 1, cTBSlow reduced inhibition in M1, 
however, there was no systematic change in motor cortical excitability following cTBS 
primed by cTBSlow or primed by sham. This lack of effect may be due to unreliable 
neuroplasticity induction in M1 following cTBS alone. In group 2, long-lasting and less 
variable changes in motor cortical excitability were found following an unconventional 
cTBS pattern. These findings confirm the variability of cTBS-induced neuroplasticity 
and highlight the importance of developing novel protocols to induce less variable 
neuroplasticity responses. 
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The Efficacy of Non-Invasive Brain Stimulation Protocols for Inducing Neuroplasticity 
in the Primary Motor Cortex 
The human adult brain is capable of changes with experience (Buonomano & 
Merzenich, 1998). This phenomenon is referred to as neuroplasticity. Neuroplastic 
changes can occur in either the brain structure (structural neuroplasticity) or in the 
strength of existing networks (functional neuroplasticity; Buonomano & Merzenich, 
1998). Functional neuroplasticity is particularly important for learning and memory 
(Buonomano & Merzenich, 1998). Evidence of functional neuroplasticity was first 
shown in the hippocampus (Kelso, Ganong, & Brown, 1986), however, more recent 
evidence suggests that the human adult cortex is capable of functional neuroplastic 
change (Buonomano & Merzenich, 1998). 
Specifically, neuroplasticity has been demonstrated in  the region of the brain 
responsible for the execution of voluntary movement (known as the primary motor 
cortex; Sanes and Donoghue, 2000). There is evidence that an increase in the 
excitability of the primary motor cortex (M1) is important for motor learning (Sanes and 
Donoghue, 2000). Consequently, there is much interest in developing techniques that 
can modulate the excitability of M1, so as to help people relearn movements after brain 
injury (e.g. stroke; Cramer et al., 2011). Non-invasive brain stimulation (NIBS) 
techniques are capable of inducing short-lasting neuroplasticity and are commonly used 
for both research and clinical purposes (Nitsche, Müller-Dahlhaus, Paulus, & Ziemann, 
2012).  
Transcranial magnetic stimulation (TMS) is a commonly used type of non-
invasive brain stimulation technique (Hallett, 2007). It is safe, painless, and has been 
used for approximately 30 years (Hallett, 2007). TMS can be used in two ways: 1) 
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single-pulse TMS can measure excitability of M1 (Hallett, 2007); 2) repetitive TMS 
(rTMS) can be used to temporarily induce short-lasting neuroplastic changes in M1 
(Fitzgerald, Fountain, & Daskalakis, 2006).  
Single-pulse Transcranial Magnetic stimulation  
In TMS, an electric pulse is sent through to a hand-held coil, placed against the 
scalp, to induce a magnetic field (Hallett, 2007). The magnetic field passes through the 
skull, with little attenuation, and induces current flow in the underlying tissue (Hallett, 
2007). When single-pulse TMS is applied to an area of M1, at a sufficient intensity, it 
causes the neuronal elements to produce action potentials. These action potentials go on 
to produce activity in the targeted muscle, referred to as a motor evoked potential 
(MEP; Hallett, 2007). The amplitude of the MEP, measured peak-to-peak, quantifies the 
excitability of the pathway from the point of stimulation to the target muscle (that is, it 
provides a measure of corticospinal excitability; Hallett, 2007).  
Repetitive Transcranial Magnetic Stimulation  
The repeated application of TMS pulses is referred to as rTMS (Fitzgerald et al., 
2006). rTMS is capable of inducing a change in excitability of the stimulated area which 
outlasts the period of stimulation (Fitzgerald et al., 2006). The effects of rTMS can be 
quantified using MEP amplitude, where a change in MEP amplitude post-rTMS 
indicates neuroplasticity induction (Fitzgerald et al., 2006).  
The direction of an rTMS-induced change in MEP amplitude depends on a 
number of stimulation parameters: these include stimulator intensity and the pattern of 
the rTMS train (Cardenas-Morales, Nowak, Kammer, Wolf, & Schonfeldt-Lecuona, 
2010). The first developed rTMS protocols consisted of stimulation at a constant 
frequency (these protocols will be referred to as conventional rTMS; Fitzgerald et al., 
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2006). In conventional rTMS, there are two patterns of stimulation (see panels A and B 
of Figure 1 for a comparison of the two patterns; Fitzgerald et al., 2006). A train of low-
frequency stimulation (≤ 1Hz) induces MEP amplitude suppression that can last for up 
to 15 minutes following stimulation cessation (Fitzgerald et al., 2006). The mechanisms 
underlying this decrease in MEP amplitude have been likened to the weakening of 
connections in neural networks within the stimulated brain region (Ziemann, 2004). 
This phenomenon is referred to as long-term depression (LTD; Ziemann, 2004). The 
other conventional rTMS pattern involves a train of high-frequency stimulation (≥ 5Hz), 
which can induce an increase in MEP amplitude for up to 30 minutes (Fitzgerald et al., 
2006). This increase in MEP amplitude is mediated by effects likened to the 
strengthening of synaptic connections underlying the stimulated neural pathway 
(Ziemann, 2004). This phenomenon is referred to as long-term potentiation (LTP; 
Ziemann, 2004). Despite these rTMS protocols being used widely in research and 
clinical settings, neuroplastic responses to these rTMS patterns vary highly between 
individuals (Maeda, Keenan, Tormos, Topka, & Pascual-Leone, 2000). Consequently, 
the potential of rTMS in both research and therapeutic settings remains limited until 
protocols that induce reliable, and long-lasting, neuroplastic responses are developed 
(Maeda et al., 2000). Therefore, there is a need to better understand how these protocols 




















Figure 1. Expected change in motor evoked potentials (MEPs) following different 
rTMS stimulation patterns. (A) Conventional low-frequency rTMS (1Hz); (B) 
conventional high-frequency rTMS (5Hz); (C) conventional cTBS.  
Continuous Theta Burst Stimulation  
A more recent development in rTMS is the patterned rTMS approach (Huang, 
Edwards, Rounis, Bhatia, & Rothwell, 2005). The most commonly used patterned 
rTMS protocol is continuous theta burst stimulation (cTBS; for a review see Chung, 
Hill, Rogasch, Hoy, & Fitzgerald, 2016). Conventionally, cTBS consists of bursts of 
three pulses of stimulation at 20ms (50Hz), repeated every 200ms (5Hz), for 40s (600 
pulses total; see panel C and insert of Figure 1; Huang et al., 2005). MEP amplitude is 
reduced following cTBS compared to sham stimulation (where sham stimulation 
provides auditory stimuli comparable to real cTBS without inducing current flow; 
Bonato, Miniussi, & Rossini, 2006; Huang et al., 2005). The decrease in MEP 
amplitude suggests a decrease in corticospinal excitability, which is mediated via LTD-
like effects (Cooke & Bliss, 2006; Huang et al., 2007). The mechanism mediating the 
effect of cTBS is referred to as LTD-like because, while it is very similar to LTD 
processes, there is insufficient evidence to conclude that this is the case (Cooke & Bliss, 
2006). Compared to conventional rTMS, cTBS is the preferred protocol for two 
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reasons: 1) cTBS induces longer-lasting neuroplastic responses; 2) cTBS uses lower 
intensity stimulation over a shorter duration (DiLazzaro et al., 2011). 
Up until approximately 2011, 18 studies supported the LTD-like effects of cTBS 
by replicating a significant depression in MEP amplitude post-cTBS (Chung et al., 
2016). However, from approximately 2011 onwards, there have been a greater number 
of reports where cTBS did not induce significant change (Hamada, Murase, Hasan, 
Balaratnam, & Rothwell, 2013; Vernet et al., 2014). For example, when Hamada et al. 
(2013) investigated the neuroplasticity inducing effects of cTBS in 52 individuals, they 
found that at the group level there was no significant change in MEP amplitude. Their 
results revealed large inter-individual variability of responses to cTBS, with 42% of 
participants showing the expected decrease in MEP amplitude, and 58% showing an 
unexpected increase in MEP amplitude (Hamada et al., 2013). It is imperative that the 
inter-individual variability in responses to cTBS be addressed, for, as previously stated, 
the inability of non-invasive brain stimulation protocols to reliably induce long-lasting 
neuroplastic responses limits their potential in both research and clinical settings 
(Maeda et al., 2000).  
Previous research has used two approaches in an attempt to reduce cTBS 
variability: 1) modify cTBS parameters (e.g. Goldsworthy, Pitcher, & Ridding, 2012a); 
2) harness factors known to influence neuroplasticity (for a review see Ridding & 
Ziemann, 2010). These will be discussed in turn. First, variability can be reduced by 
modifying cTBS parameters. For example, Goldsworthy et al. (2012a) compared the 
efficacy of two cTBS patterns. The first cTBS pattern was the Huang et al. (2005) 
paradigm (outlined above), and the second cTBS pattern used stimulation parameters 
developed by Nyffeler et al. (2006). The Nyffeler et al. (2006) pattern involved bursts of 
three pulses of stimulation at 33.3ms (30Hz), repeated every 167ms (6Hz), for 33.3s 
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(see Figure 2 for a comparison of the Huang and Nyffeler cTBS paradigms). 
Goldsworthy and colleagues’ (2012a) results indicated that the Nyffeler et al. (2006) 
paradigm-induced a more consistent change in MEP amplitude. This finding 
emphasised the importance of further investigating different patterns to optimise 
neuroplasticity-induction (Goldsworthy et al., 2012a).  
Figure 2. Stimulation patterns of two cTBS protocols. Adapted from “A Comparison of 
Two Different Continuous Theta Burst Stimulation Paradigms Applied to the Human 
Primary Motor Cortex,” by Goldsworthy et al., 2012a, Clinical Neurophysiology, 123, 
p. 2257.  
Second, there are a number of inter-individual factors that influence 
neuroplasticity induction which can be harnessed to reduce cTBS response variability 
(see Ridding & Ziemann, 2010). For example, attention and exercise are 
neuroplasticity-influencing factors that have recently been reviewed (Ridding & 
Ziemann, 2010). Of identified factors, there is strong evidence to suggest that an easily 
modifiable factor, inhibition, plays a major role in neuroplasticity induction (Ziemann, 
Corwell, & Cohen, 1998).  
Inhibition and Neuroplasticity Induction  
There are inhibitory networks all throughout the brain, including M1 (Kalat, 
2013). Inhibition is an active process which, in M1, is capable of suppressing the 
excitability of cortical motor neurons (Kalat, 2013). A number of animal studies have 
investigated the role of inhibition in neuroplasticity induction (Hess, Aizenman, & 
Donoghue, 1996). These studies show that reducing inhibition (pharmacologically) 
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enhances neuroplasticity in the motor cortex by unmasking pre-existing excitatory 
processes (Jacobs & Donoghue, 1991). The role of inhibition in neuroplasticity 
induction has also been examined in the M1 of conscious humans (e.g. Ziemann et al., 
1998). In Ziemann and colleagues’ (1998) study, rTMS was primed by a protocol that 
reduces inhibition in M1 (through the temporary removal of sensory input from the 
hand to the brain). Results showed that rTMS led to a significant increase in MEP 
amplitude when applied following the priming condition, but not when applied alone 
(Ziemann et al., 1998). In light of this evidence, it is plausible that reducing inhibition 
prior to the application of rTMS would reduce response variability. 
Paired-pulse TMS can be used to measure the inhibitory processes acting within 
M1 (i.e. intracortical inhibition; Kujrai et al., 1993). As previously explained, when 
single-pulse TMS is applied to an area of M1, an MEP is elicited, which provides a 
measure of corticospinal excitability (Hallett, 2007). In contrast, paired-pulse TMS 
involves two stimuli: a conditioning stimulus which precedes a test stimulus at an 
interval of 3ms (Kujrai et al., 1993). While the conditioning stimulus is not of a 
sufficient intensity to elicit an MEP, it activates intracortical inhibitory circuits (Kujrai 
et al., 1993). Activation of these circuits, by the conditioning stimulus, results in an 
inhibitory effect on the MEP elicited by the test stimulus (Kujrai et al., 1993). By 
comparing the MEP elicited by single-pulse TMS to the MEP elicited by paired-pulse 
TMS it is possible to obtain a measure of intracortical inhibition, referred to as short-
interval intracortical inhibition (SICI; Kujrai et al., 1993).  
Recent work has investigated whether a modified cTBS protocol can be used to 
reduce intracortical inhibition (McAllister, Rothwell, and Ridding, 2009). McAllister et 
al., (2009) found that cTBS, set at a lower than conventional intensity, down-regulates 
inhibition in the stimulated region of M1. In light of the research above, this inhibition-
EFFICACY OF NON-INVASIVE BRAIN STIMULATION 14 
reducing, low intensity, cTBS protocol (cTBSlow) might make the brain more amenable 
to plasticity induction. If so, cTBSlow may be able to prime cTBS of a conventional 
intensity to induce a more reliable plastic response. Consequently, priming with 
cTBSlow might reduce the impact of inter-individual variability as a limitation of cTBS.  
The priming effect of cTBSlow, on conventional cTBS, has been investigated by 
Murakami and colleagues (2012). Their results showed that the change in MEP after 
cTBS primed by cTBSlow was not different from the change in MEP after cTBS alone 
(Murakami et al., 2012). This finding suggests that priming with cTBSlow does not 
affect cTBS-induced neuroplasticity (Murakami et al., 2012). However, Murakami et al. 
(2012), investigated the priming effect of cTBSlow on the Huang et al. (2005) protocol, 
which is not the most consistent neuroplasticity-inducing cTBS protocol (Goldsworthy 
et al., 2012a). As previously mentioned, the change in MEP amplitude following the 
Nyffeler et al. (2006) cTBS pattern is greater and more consistent compared to the 
Huang et al. (2005) pattern (Goldsworthy et al., 2012a). Given that slight changes in 
stimulation, characteristics can influence the neuroplastic response, it is important to 
investigate the priming effect of cTBSlow on the most effective single-train protocol, 
based on the available literature (Goldsworthy et al., 2012a). Therefore, instead of 
priming the Huang et al. (2005) cTBS protocol, the present study investigated the 
priming effects of cTBSlow on the Nyffeler et al. (2006) protocol (cTBSNyffeler). 
Aim and Hypotheses  
The aim of the current study was to determine whether cTBSlow could reduce 
inhibition, and prime M1, so that cTBSNyffeler could induce a more consistent 
neuroplastic response compared to cTBSNyffeler primed by sham stimulation (cTBSsham). 
To investigate this, responses to single- and paired-pulse TMS were recorded from an 
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intrinsic hand muscle. As mentioned previously, both single- and paired-pulse TMS 
allows the investigation of changes in corticospinal excitability (indicative of 
neuroplasticity induction) and SICI (indicative of intracortical inhibition modulation), 
respectively. Thus MEPs and SICI were recorded at baseline, following the first train of 
cTBS (i.e. cTBSlow or cTBSsham), and intermittently over 45 minutes post-cTBSNyffeler. 
To adequately compare the two proposed protocols, the current study implemented a 
sham-controlled, within-subjects design. The within-subjects design ensured that inter-
variability in responses to the different neuroplasticity-inducing protocols would not 
confound the results. Additionally, the application of cTBSsham in the control condition, 
in place of cTBSlow, reduced the possibility that the effects of cTBSlow were due to 
factors other than the stimulation itself. 
The research aim (stated above) was addressed by three key hypotheses. As 
previously mentioned, McAllister et al. (2009) found that cTBSlow down-regulated SICI. 
In light of this result, it was first hypothesised that SICI would decrease following 
cTBSlow, but would not change following cTBSsham (that is, SICI would not significantly 
change after no stimulation). As per evidence from animal and human studies, a 
reduction in intracortical inhibition will make the brain more amenable to 
neuroplasticity induction (Ziemann et al., 1998). Therefore, the second hypothesis was 
that there would be a greater decrease in MEP amplitude following cTBSNyffeler primed 
by cTBSlow (i.e. primed cTBSNyffeler), compared to cTBSNyffeler primed by cTBSsham (i.e. 
cTBSNyffeler alone). Furthermore, if a reduction in SICI makes the brain more amenable 
to neuroplasticity induction (as per the rationale of the second hypothesis), then a 
greater reduction in SICI would be associated with a greater neuroplastic response to 
cTBSNyffeler (i.e. a greater decrease in MEP amplitude). Thus, the third hypothesis was 
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that there would be a positive linear relationship between a decrease in SICI following 
cTBSlow and a decrease in MEP amplitude following primed cTBSNyffeler. 
Method 
Participants  
Thirty-eight participants completed data collection (23 females; 18-33 years of 
age; M = 22.79, SD = 3.85). Six participants (4 females; 21-30 years of age; M = 24.83, 
SD = 3.92) attended a single pilot session, and the remaining 32 participants (19 
females; 18-33 years of age; M = 22.41, SD = 3.77) participated in the experimental 
phase, which comprised of two sessions. The sample size of the experimental phase (n = 
32) allowed for the results to be comparable to most previous research regarding the 
effects of cTBS on M1 in young adults (N ≤  20; Chung et al., 2016), and comparable to 
a number of studies assessing the inter-individual variability of TBS responses (N ≤ 30; 
e.g. Hinder et al., 2014; Vallence et al., 2015). Participants were recruited from the 
student population via an electronic portal as part of their course credit, and from the 
general public by word-of-mouth. All 38 participants were deemed eligible for TMS 
following a screening of their relevant medical history, as per the international 
guidelines for the safe use of TMS (see Appendix A; Rossi, Hallett, Rossini, & Pascual-
Leone, 2011). Additionally, recruited participants were restricted to right-handed 
individuals, as indicated by the Edinburgh Handedness Inventory (see Appendix B; 
Oldfield, 1971). Handedness was restricted due to evidence demonstrating differences 
in hemispheric asymmetries in left- and right-handed people (Triggs, Subramanium, 
Rossi, 1999), and evidence of greater TMS-induced neuroplasticity in the dominant 
hemisphere (Ridding & Flavel, 2006).  
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Prior to their involvement, participants read an information letter regarding the 
methods used in the experiment, were given the opportunity to ask questions, and gave 
written informed consent (see Appendices C and D). Data was collected from all 
participants at a psychophysiology laboratory at Murdoch University. This study had 
ethical approval from the Murdoch University Human Research Ethics Committee (see 
Appendix E).  
Design 
The experimental phase was a participant-blinded, within-subjects design. The 
independent variable was protocol, of which there were two conditions: the protocol 
applied in the cTBSlow condition was cTBSlow primed cTBSNyffeler, and the protocol 
delivered in the cTBSsham condition was cTBSsham primed cTBSNyffeler. Order of protocol 
was counter-balanced across participants. MEP amplitude and SICI were the two 
dependent variables.  
Materials and Procedures  
Recordings. Electromyographic (EMG) signals were recorded from the right 
first-dorsal interosseous (FDI) using Ag/AgCl cup electrodes placed in a belly-tendon 
configuration (see Figure 3). The FDI was targeted due to its large representation in M1, 
which allows corticospinal excitability to be reliably measured (Malcolm et al., 2006; 
Reilly & Mercier, 2007). Furthermore, the FDI is an intrinsic hand muscle for motor 
learning and fine motor control, therefore targeting this muscle was functionally 
valuable (Lang & Schieber, 2003). The raw electrode signal from the FDI was amplified 
1000 times (CED 1902 amplifier) and band pass filtered (20-1000Hz).  The signal was 
then digitized at a sampling value of 5kHz (CED Power1401), and EMG data were 
stored on a computer for offline analysis (Signal version 6.02). 








Figure 3. Belly-tendon electrode configuration for FDI. Electrode A recorded muscle 
activity from the belly of the FDI. Electrode B was placed on a metacarpophalangeal 
joint to account for measurements of non-muscular activity in electrode A. The recorded 
EMG activity was the difference between electrodes A and B, which provided muscle 
activity with a good signal-to-noise ratio. Electrodes C and D were grounding electrodes 
for electrical activity. 
Transcranial magnetic stimulation. Single- and paired-pulse stimulation was 
delivered with a Magstim BiStim 2002 (Magstim, Whitland, Dyfed, UK) via a 90mm 
figure-of-eight coil. Additionally, cTBS was delivered using a Magstim Rapid 
(Magstim, Whitland, Dyfed, UK) via a 70mm air-cooled figure-of-eight coil. The coil 
was placed tangentially to the scalp with the handle pointed backward, 45° away from 
the midline (that is, at the optimal coil orientation for inducing current flow in M1; 
Janssen, Oostendorp, & Stegeman, 2015). 
The optimal site on the scalp for evoking MEPs for contralateral FDI of the right 
hand was located using suprathreshold single-pulse TMS. The optimal site evokes the 
largest and most reliable MEPs and is referred to as the hotspot (Saisanen et al., 2008). 
Once the hotspot was determined, the scalp was marked for all following placements of 
the coil. The hotspot was determined and marked separately using the Magstim BiStim 
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Single-pulse TMS was used to determine three intensities: resting motor threshold 
(RMT), active motor threshold (AMT), and the stimulator intensity required to evoke 
MEP amplitudes between approximately 0.5 and 1mV (known as SI1mV). RMT was 
defined as the minimum stimulator intensity to evoke MEPs of at least 50µV in 
amplitude, in at least five out of ten consecutive trials, while the right FDI was relaxed 
(Hamada et al., 2013; Mori et al., 2013). RMT was measured twice; once using the 
BiStim (i.e. RMTBiStim) and once with the Rapid (i.e. RMTRapid). Second, AMT was 
determined. AMT was defined as the minimum stimulator intensity required to evoke 
MEPs of at least 200µV, in at least five out of ten consecutive trials, whilst the 
participant maintained a voluntary FDI contraction of 10% of their maximum voluntary 
contraction (Hamada et al., 2013; Mori et al., 2013). To aid participants in maintaining 
this contraction, real-time feedback was given via target EMG activity presented on 
screen. AMT was measured using the Rapid at the end of the second experimental 
session. Third, SI1mV was obtained by adjusting the stimulator intensity to evoke MEP 
amplitudes between approximately 0.5 and 1mV (Silbert, Patterson, Pevcic, Windnagel, 
& Thickbroom, 2013). SI1mV was measured with the BiStim. 
Pilot data collection. Previous studies have either set the stimulator intensity for 
cTBS application relative to RMT or AMT (Chung et al., 2016). However, setting cTBS 
intensities relative to AMT can be problematic, for sustaining a contraction prior to 
cTBS can reduce the neuroplastic response (Huang, Rothwell, Edwards, & Chen, 2008). 
To eliminate the potential effect of contraction on cTBS response in the current study 
cTBS could not be set relative to AMT. However, previous research using cTBSlow set 
cTBS intensity relative to AMT (McAllister et al., 2009). Therefore, before running the 
experiment, pilot data was collected so that AMT could be reliably estimated from each 
individual’s RMT.   
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During pilot data collection, single-pulse TMS was delivered with the Rapid to 
determine each participant’s FDI hotspot, RMT, and AMT (as described above). To 
generate a formula for estimating AMT, the actual AMT was expressed as a ratio of 
AMT to RMT for each participant. The group level AMT was 82% of RMT (data 
presented in Table 1). Therefore, to estimate AMT, the current study used the following 
formula: estimated AMT = RMTRapid × .82.  
Table 1  







Note. RMT = resting motor threshold. AMT = active motor threshold. % of MSO = 
percentage of maximum stimulator output.  
Experimental protocols.   
MEP amplitude and SICI. Single-pulse TMS was applied at SI1mV to measure 
MEP amplitude. SI1mV was used because 1mV is considered a moderately sized 
response, which has the capacity to increase or decrease (Silbert et al., 2013). To 
measure SICI, paired-pulse TMS was applied. The intensity of the first pulse (i.e. the 
conditioning stimulus) was set at 70% RMT (Vucic, Cheah, Krishnan, Burke, & 
Kiernan, 2009), the intensity of the second pulse (i.e. the test stimulus) was set at SI1mV 
Participant RMT (% of MSO) AMT (% of MSO) (AMT/RMT) × 100 (%) 
1 56 46 82 
2 57 45 79 
3 57 47 82 
4 50 32 64 
5 53 48 91 
6 65 60 92 
  Mean 82 
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(Silbert et al., 2013), and the inter-stimulus interval was 3ms (McAllister et al., 2009). 
For a reliable measure of MEP amplitude and SICI, baseline measurements comprised 
of three blocks of 20 single- and 20 paired-pulse stimuli (Goldsworthy, Hordacre, & 
Ridding, 2016). Single and paired-pulse trials were psuedorandomised within each 
block, and the inter-trial interval was five seconds (± 20% to reduce anticipation). In-
between each block, the mean and standard deviation of the 20 single-pulse trials was 
calculated to ensure that there was a consistent and stable measure of corticospinal 
excitability at baseline. 
cTBSlow. Short bursts of three pulses were delivered at 20ms (50Hz), repeated 
every 200ms (5Hz), for 40s (600 pulses total; Huang et al., 2005). The intensity of was 
set to 70% of estimated AMT (calculated for each individual by multiplying RMTRapid 
by 0.82; to evaluate how closely this study estimated AMT, each participant’s actual 
AMT was determined at the end of the second session; McAllister et al., 2009).  
cTBSNyffeler.  Short bursts of three pulses were delivered at 33ms (30Hz), every 
167ms (6Hz), for 33.3s (600 pulses total; see panel B of Figure 5; Nyffeler et al., 2006). 
The intensity of cTBSNyffeler was set to 80% of RMT (Nyffeler et al., 2006). 
cTBSsham. In the control session, a sham coil was used to mimic the auditory 
sensation of cTBSlow, without inducing current flow in the brain (Bonato et al., 2006).  
Experiment procedure. Each participant attended two sessions; an experimental 
session and a control session. Sessions were separated by at least 2 days to allow for any 
cTBS-induced changes to washout (Goldsworthy, Pitcher, & Ridding, 2012b; Todd, 
Flavel, & Ridding, 2009). An rTMS-induced change in MEP is greater in the afternoon, 
therefore individual participants were tested at same time of day so that individual 
differences in MEP amplitude between sessions could not be attributed to the time of 
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testing (Sale, Ridding, & Nordstrom, 2007). See Figure 4 for a schematic of the 
experimental timeline. RMTBiStim, SI1mV, and RMTRapid were measured prior to baseline 
measurements, to tailor the intensity of the conditioning stimulus, test stimulus, and 
cTBS protocols to each individual, respectively. Both MEP amplitude and SICI were 
measured at baseline, after the priming paradigm (either cTBSlow or cTBSsham), and at 
six time-points following cTBSNyffeler (0, 5, 10, 20, 30, and 45 min post). The inter-train 
interval was 10 minutes, in both conditions. There were two reasons for choosing this 
inter-interval: 1) the greatest reduction in SICI occurs between 5 and 20 minutes post-
cTBSlow (McAllister et al., 2009); 2) response to cTBS is greater following two 
applications of cTBS spaced at 10 minutes (relative to a single-application of cTBS; 










Figure 4. Schematic of the experimental timeline.  
 
Unforeseen Technical Issue Identified During Data Collection 
Distinct auditory stimuli are associated with bursts of cTBS pulses. Part-way 
through data collection (after 43 sessions) a distortion in auditory stimuli was noticed by 
the experimenter. The session was immediately stopped, and a systematic investigation 
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where in a cTBS train pulses were skipped, and to determine whether the issue was 
persistent.  
 
The output of cTBS pulses was recorded for each cTBS intensity that had been 
used to stimulate participants. Outputs were recorded for both cTBSlow and cTBSNyffeler 
stimulator intensities. Each intensity was tested three times (in a randomised order). For 
each recorded stimulator intensity, all 200 bursts of stimulation were viewed to 
determine if a pulse had skipped, and if so, at what point in the train this had occurred. 
This systematic investigation showed that, for the cTBSlow/sham, and cTBSNyffeler 
paradigms, there was a systematic skipping of pulses (see Figure 5 for a schematic of 
the conventional and unconventional cTBS patterns). For cTBSlow, the middle pulse was 
skipped for intensities ≥ 30% of maximum stimulator output (MSO; as shown in panel 
C of Figure 5). For cTBSNyffeler, the middle pulse was skipped for intensities ≥ 53% of 
MSO (as shown in panel D of Figure 5). For both cTBSlow and cTBSNyffeler, there was 
one stimulator intensity (52% MSO) for which pulses skipped intermittently. It was for 
this intensity only that the auditory stimuli of bursts were distorted, and it was during an 
experimental session of this intensity that the experimenter identified the technical 
issue. It was determined that this issue was not the result of a human error in 


















Figure 5. Schematic of the pulse configurations in each of the cTBS paradigms. Panel’s 
A and B illustrate the conventional patterns of stimulation, with a three-pulse burst. 
Panel’s C and D illustrate the unconventional patterns of stimulation, with only two 
pulses per burst. Adapted from “A Comparison of Two Different Continuous Theta 
Burst Stimulation Paradigms Applied to the Human Primary Motor Cortex,” by 
Goldsworthy et al., 2012a, Clinical Neurophysiology, 123, p. 2257.  
For 21 (of 25) participants whose data had been collected up until this point, 
patterns of either one or both of the cTBS trains were not delivered as planned. Given 
that pulses were systematically and consistently skipped, individual participants were 
divided into three groups based on the pattern of stimulation they had received for both 
paradigms: the planned group, planned Nyffeler group, or unplanned group. Firstly, the 
planned group (n = 14) received both paradigms at their planned pattern of stimulation 
(i.e. three pulses per burst). Secondly, the planned Nyffeler group (n = 12) received the 
cTBSNyffeler paradigm at its planned pattern but received cTBSlow at an unplanned 
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pattern (i.e. two pulses at 25Hz; 400 pulses total; see Figure 5C). Third, the unplanned 
group (n = 6) received both paradigms at an unplanned pattern (i.e. two pulses per burst 
in each paradigm; 400 pulses total per paradigm; see panels C and D of Figure 5). It is 
important to note the small sample size for the unplanned group (n = 6), relative to the 
intended sample of N = 30. This small sample does not allow for these data to be 
interpreted, therefore these results have not been presented in the main text of the 
current study. 
Data Exclusions and Analyses   
Participant exclusion during data collection. Forty-nine healthy adults were 
originally recruited for data collection. Three participants completed the first session but 
could not attend the second session due to unforeseen circumstances, and eight were 
excluded from completing the first session. There were two reasons for excluding 
participants from completing the first session, these will be discussed in turn. First, 
three participants were excluded from further testing because the stimulator intensity 
required to evoke MEPs exceeded 75% of BiStim MSO (MSOs greater than 75% can 
overheat the coil). Second, five participants were excluded because more than 30% of 
trials had EMG activity of  > 0.02mV in the 265ms leading up to the MEP, which would 
have contaminated the recorded MEPs. If less than 30% of trials were contaminated, 
participants continued and contaminated trials were excluded from data analysis.  
Data screening. Prior to data analysis, baseline MEP amplitudes and SICI ratios 
were screened for outliers. Outliers were identified as values ±2 SD above the mean. 
For baseline MEP amplitude, one individual in the planned group was identified as an 
outlier. This individual was excluded from all MEP analyses. Additionally, two outliers 
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were identified in baseline SICI ratios: one in the planned group; the other in the 
planned Nyffeler group. These two participants were excluded from all SICI analyses. 
Data analysis. For each trial, MEP amplitude was measured peak-to-peak 
between 12ms and 42ms post-test stimulus. SICI was quantified by creating a ratio of 
the average paired-pulse MEP amplitudes in a block to the average single-pulse MEP 
amplitudes in a block. For all analyses post-cTBS (that is, immediately post-cTBSlow, 
immediately post-cTBSsham, or post-cTBSNyffeler) raw MEP amplitude and SICI ratios 
were normalised to baseline. That is, for each post-cTBS block, MEP amplitude and 
SICI was expressed as a ratio of average baseline (where average baseline was the mean 
of the three baseline blocks). Due to the different patterns of cTBS the groups received, 
these data were analysed separately. Given that technical issues during data collection 
resulted in three separate and likely underpowered groups, statistical analyses in the 
current study were considered exploratory. Consequently, multiple comparisons were 
not corrected for, therefore the results should be interpreted with caution as they are at a 
high risk of type I error. Statistical significance was accepted at a p value of < .05. Due 
to the technical difficulties and likely underpowered samples in the current study, 
results approaching significance at a p value of ≤ .06 have also been highlighted. 
Across groups. Independent-samples t-tests were performed to test for group 
differences in baseline neurophysiological characteristics (including age, RMTRapid, 
SI1mV, average raw baseline MEP amplitude, and average baseline SICI ratios). Separate 
t-tests were performed for each characteristic.  
Within groups. Within each group, baseline neurophysiological characteristics (as 
above) were compared between the two conditions with paired-samples t-tests (where 
the cTBSlow condition refers to cTBSlow primed cTBSNyffeler, and the cTBSsham condition 
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refers to cTBSsham primed cTBSNyffeler). To investigate whether MEP or SICI changed 
from baseline following the first train of cTBS (i.e. post-cTBSlow or post-cTBSsham), 
normalised data at the mid-point were compared to baseline (i.e. 1.00) with single-
sample t-tests. To determine whether MEP and SICI changed post-cTBSNyffeler primed 
by cTBSlow or cTBSsham, two-way repeated measures (RM) ANOVAs were performed 
on the normalised MEP amplitude and normalised SICI of the two conditions. Separate 
analyses were performed for MEP and SICI. The within-subjects factors were 
PROTOCOL (2 levels: cTBS_low and cTBS_sham) and TIME (6 levels: 0, 5, 10, 20, 
30, and 45 min). To determine whether MEP and SICI post-cTBSNyffeler significantly 
differed from baseline, single-sample t-tests were conducted on normalised MEPs and 
normalised SICI at each time-point following cTBSNyffeler, for both conditions.  
Associations. To determine whether a change in SICI immediately following 
cTBSlow was associated with the average change in MEP post-cTBSNyffeler in the planned 
group, Pearson’s r correlations were performed on normalised SICI at the mid-point and 
the mean change in normalised MEP amplitude post-cTBNyffeler. The average change in 
MEP amplitude was determined by calculating mean MEP amplitude across all time 
points following the second train of stimulation. Correlates were performed separately 
for cTBSlow and cTBSsham conditions. To determine whether the change in MEP at the 
mid-point was associated with a change in MEP post-Nyffeler in the planned Nyffeler 
group, Pearson’s r correlations were also performed on MEP amplitude at the 
normalised mid-point, and the average change in normalised MEP amplitude post-
cTBNyffeler. The average change in MEP amplitude was determined in the same manner 
as in the planned group (above). Separate correlations for cTBSlow and cTBSsham 
conditions.  
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AMT. To gauge whether estimating AMT might have influenced responses to 
cTBSlow, a paired-samples t-test was used to compare cTBSlow stimulator intensities set 







Across all data analyses, assumptions of normality, normality of difference scores, 
homogeneity of variance, linearity, and homoscedasticity were tested. Normality and 
normality of difference scores were assessed with the Shapiro-Wilk statistic and, where 
relevant, through visual inspection of histograms. Homogeneity of variance was 
assessed for with Levene’s statistic for independent-samples t-tests and Fmax for two-
way RM ANOVAs (Tabachnick & Fidell, 2007). While a number of measures violated 
a number of these assumptions, most parametric tests are relatively robust to moderate 
violations (Tabachnick & Fidell, 2007). Therefore, all measures that violated any of the 
above assumptions were analysed and interpreted with non-corrected parametric tests. 
However, corrections were made in analyses where the assumption of sphericity was 
violated. For all two-way repeated measures ANOVAs the assumption of sphericity was 
assessed with Mauchly’s test. Where violated, degrees of freedom were adjusted with 
the Huynh-Feldt Epsilon (Tabachnick & Fidell, 2007). 
Demographic and Baseline Neurophysiological Characteristics  
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Table 2 outlines the demographic characteristics of the planned and planned 
Nyffeler groups. An independent-samples t-test revealed that the planned group was 
significantly younger than the planned Nyffeler group (t(24) = -3.24, p = .003, d = .76).  
Table 2  
Demographic Characteristics for Participants in the Planned and Planned Nyffeler 
Groups  
Group N % Female Age Range (M, SD) % tested in afternoon 
Planned 14 78.57 18 - 24 (20.07, 1.64) 71.43 
Planned Nyffeler 12 41.67 18 - 29 (23.25, 3.22) 58.33 
 
Table 3 summarises the average stimulator intensities used in each group. An 
independent-samples t-test revealed that the planned group had a significantly lower 
RMTRapid than the planned Nyffeler group (t(50) = -2.46, p = .02, d = 0.67). Separate 
independent-samples t-tests showed that the planned group had a significantly larger 
mean baseline MEP than the planned Nyffeler group (t(46) = 2.38, p = .02, d = .52) 
while mean baseline SICI ratios were not significantly different (t(46) = -1.28, p = .21 d 
= 0.13). 
Table 3  
Mean (Standard Deviation) Stimulator Intensities (expressed as a percentage of 
maximum stimulator output) For the Planned and Planned Nyffeler Groups 






Planned 45.86 (6.04) 53.57 (7.22) 53.61(7.84) 44.43 (5.37) 45.64 (8.04) 
Planned Nyffeler 49.54 (4.46) 57.58 (3.66) 60.21 (7.35) 46.50 (3.12) 46.00 (3.67) 
Note. RMTBiStim = resting motor threshold obtained with the Magstim BiStim 2002. 
RMTRapid = resting motor threshold obtained with the Magstim Rapid. SI1mV = the 
stimulus intensity required to produce motor evoked potentials of approximately 0.5-
1mV in amplitude. AMT = active motor threshold. Estimated AMT = RMT × 0.82.  
Planned Group 
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Baseline neurophysiological characteristics. Table 4 summarises the baseline 
neurophysiological characteristics of each condition in the planned group (where the 
cTBSlow condition refers to cTBSlow primed cTBSNyffeler, and the cTBSsham condition 
refers to cTBSsham primed cTBSNyffeler). Paired-samples t-tests were performed on 
several baseline neurophysiological characteristics to determine whether there was a 
systematic difference between the cTBSlow and cTBSsham conditions. The two conditions 
did not significantly differ in RMTRapid, SI1mV, mean baseline MEP amplitude, or mean 
baseline SICI ratio (t(12) ≤ 2.19, p ≥ .05, d ≤ 0.32).  
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Table 4  
Baseline Neurophysiological Characteristics of the cTBSlow and cTBSsham Conditions in 
the Planned Group 
 cTBSlow  cTBSsham 
 M SD  M SD 
RMTRapid (% of MSO) 53.64 7.71  53.50 6.98 
SI1mV (% of MSO) 54.36 8.40  52.86 7.48 
Baseline MEP amplitude (mV) 1.11 0.18  1.06 0.13 
Baseline SICI ratio (mV) 0.30 0.28  0.37 0.28 
Note. % of MSO = percentage of maximum stimulator output. RMTRapid = resting motor 
threshold obtained with the Magstim Rapid. SI1mV = the stimulus intensity required to 
produce motor evoked potentials of approximately 0.5-1mV in amplitude. MEP = motor 
evoked potential. SICI = short-interval intracortical inhibition. 
Post-cTBSlow. Figure 6 shows the change in MEP amplitude in the planned group, 
and panel A shows the time-course of this change. The orange frame in panel A of 
Figure 6 highlights the change in MEP amplitude immediately following cTBSlow and 
cTBSsham. Single-sample t-tests were performed on normalised MEP amplitude at the 
mid-point (i.e. the point between the first and second train of cTBS) to determine 
whether MEP was modulated by the first train of cTBS (i.e. cTBSlow or cTBSsham). 
Following the first train of cTBS, MEP amplitude did not significantly change from 
baseline (i.e. 1.00) in either the cTBSlow (t(12) = -1.77, p = .10, d = 0.48) or cTBSsham 
(t(12) = -1.13, p = .28, d = 0.32) conditions. Figure 7 shows the time course of change 
in SICI. The orange frame in Figure 7 highlights the change in SICI immediately 
following cTBSlow and cTBSsham. Single-sample t-tests were performed on normalised 
SICI at the mid-point to determine whether SICI was modulated by the first train of 
cTBS. Relative to baseline, SICI was significantly reduced post-cTBSlow (t(12) = 2.61, p 






















Figure 6. MEP amplitude expressed as a percentage of baseline post-cTBS. (A) The 
time course of change in both cTBSlow (open symbol) and cTBSsham (filled symbol) 
conditions. Time-points are horizontally offset so that error bars are visible. Error bars 
represent standard error of the mean. The orange frame highlights the change in MEP 
following the first train of cTBS. (B and C) Comparison of inter-individual variability 
in responses, to both cTBSlow and cTBSsham protocols, respectively. Response profiles 
are expressed as the mean percentage change in MEP amplitude (bars below 0 reflect 
expected decrease in MEP amplitude, bars above 0 reflect increase in MEP amplitude 
post-cTBSNyffeler). The mean percentage change in MEP amplitude was determined by 
















Figure 7. SICI expressed as a percentage of baseline post-cTBS for the two conditions. 
Depicts the time course of SICI change in both cTBSlow (open symbols) and cTBSsham 
(filled symbols) conditions. The orange frame highlights the change in SICI following 
the first train of cTBS. Black * = reflects that this time-point in the cTBSlow condition is 
significantly different from baseline (p < .05). Time-points are horizontally offset so 
that error bars are visible. Error bars represent standard error of the mean. 
Post-cTBSNyffeler. All data points outside of the orange frame in panel A of Figure 
6 show the time-course of change in MEP following cTBSNyffeler primed by either 
cTBSlow or cTBSsham. A two-way RM ANOVA was performed to determine whether the 
change in MEP amplitude post-cTBSNyffeler in the cTBSlow condition was significantly 
different than the change in MEP amplitude postcTBSsham cTBSNyffeler in the cTBSsham 
condition. There were no significant main effects or interactions (F ≤ 2.64, p ≥ .08, ηp 2 
≤ 0.18). Single-sample t-tests were performed on normalised MEP amplitude, at all 
post-cTBSNyffeler time-points, to determine whether MEP was modulated post-
cTBSNyffeler in either condition. MEP amplitude post-cTBSNyffeler did not significantly 
differ from baseline (i.e. 1.00) at any of the time-points in either the cTBSlow (t(12) ≤ 
0.50, p ≥ .13) or cTBSsham condition (t(12) ≤ 2.01, p ≥ .07). Panel B of Figure 6 shows 
the mean change in MEP amplitude post-cTBSNyffeler for the cTBSlow condition, and 
panel C of Figure 6 shows the mean change in MEP amplitude post-cTBSNyffeler for the 
cTBSsham condition. In the cTBSlow condition, 62% of participants responded with 
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overall MEP depression, while 23% of participants in the cTBSsham condition responded 
with an overall MEP depression.  
All data points outside of the orange frame in Figure 7 show the time-course of 
change in SICI following cTBSNyffeler primed by either cTBSlow or cTBSsham. A two-way 
RM ANOVA was performed to determine whether the change in SICI post-cTBSNyffeler 
in the cTBSlow condition was significantly different from the change in SICI in the 
cTBSsham condition. The main effect of PROTOCOL approached statistical significance 
(F (1, 12) = 4.93, p = .05, ηp 2 = 0.29). There were no other main effects or interactions 
approaching or reaching statistical significance (F ≤ 0.84, p ≥ .55, ηp 2 ≤ 0.07). Single-
sample t-tests were performed on normalised SICI at all post-cTBSNyffeler time-points to 
determine whether SICI was modulated post-cTBSNyffeler, in either condition. There was 
a significant decrease in SICI, relative to baseline (i.e. 1.00), at 45 minutes post-
cTBSNyffeler in the cTBSlow condition (t(12) = 2.37, p =.04, d = 0.67). Additionally, there 
was a numerical decrease in SICI at 5 and 30 minutes post-cTBSNyffeler, in the cTBSlow 
condition, that approached statistical significance (5 minutes: t(12) = 2.17, p = .05, d = 
0.60; 30 minutes: t(12) = 2.08, p = .06, d = 0.57). There was no change in SICI for the 
remaining time-points (i.e. 0, 10, and 20 minutes) post-cTBSNyffeler in the cTBSlow 
condition (t(12) ≤ 1.37, p ≥ .20). Furthermore, single-sample t-tests showed no 
significant change in SICI post-cTBSNyffeler in the cTBSsham condition (t(12) ≤ 1.37, p ≥ 
.20).  
Associations. Pearson’s r correlations were performed to determine whether the 
change in SICI immediately following the first train of cTBS (i.e. cTBSlow or cTBSsham) 
was associated with the average change in MEP post-cTBSNyffeler in either condition. 
The average change in MEP amplitude post-cTBS and the change in SICI following the 
EFFICACY OF NON-INVASIVE BRAIN STIMULATION 35 
first train of cTBS were not significantly related in either the cTBSlow (r(12) = .15, p = 
.64) or cTBSsham (r(12) = .03, p = .93) conditions. 
Planned Nyffeler Group 
Baseline neurophysiological characteristics. Table 5 summarises the baseline 
neurophysiological characteristics of each condition in the planned Nyffeler group. 
Paired-samples t-tests were performed on several baseline neurophysiological 
characteristics to determine whether there was a systematic difference between the 
cTBSlow and cTBSsham conditions. The two conditions did not significantly differ in 
SI1mV, raw mean baseline MEP amplitude, or mean baseline SICI ratio (t ≤ 0.88, p ≥ .15, 
d ≤ 0.46). RMT was significantly higher in the cTBSsham condition compared to the 
cTBSlow condition (t(11) = -2.38, p = .04, d = 0.46). 
Table 5  
Baseline Neurophysiological Characteristics of the Real and Sham Conditions in the 
Planned Nyffeler Group 
 cTBSlow  cTBSsham 
 M SD  M SD 
RMTRapid (% of MSO) 56.75 3.84  58.42 3.42 
SI1mV (% of MSO) 59.75 8.11  60.67 6.83 
Baseline MEP amplitude (mV) 1.00 0.21  0.94 0.17 
Baseline SICI ratio (mV) 0.42 0.37  0.49 0.43 
Note. % of MSO = percentage of maximum stimulator output. RMTRapid = resting motor 
threshold obtained with the Magstim Rapid. SI1mV = the stimulus intensity required to 
produce motor evoked potentials of approximately 0.5-1mV in amplitude. MEP = motor 
evoked potential. SICI = short-interval intracortical inhibition. 
Post-cTBSlow. Figure 8 shows the change in MEP amplitude in the planned 
Nyffeler group, and panel A shows the time-course of this change. The orange frame in 
panel A of Figure 8 highlights the change in MEP amplitude immediately following 
cTBSlow and cTBSsham. Single-sample t-tests were performed on normalised MEP 
amplitude at the mid-point to determine whether MEP was modulated by the first train 
of cTBS (i.e. cTBSlow or cTBSsham). There was a significant decrease in MEP amplitude 
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from baseline (i.e. 1.00), post-cTBSlow (t(11) = -2.66, p = .02, d = 0.79), but no change 
post-cTBSsham (t(11) = 0.55, p = .59, d = 0.15). The orange frame in panel A of Figure 9 
highlights the change in SICI immediately following cTBSlow and cTBSsham. Single-
sample t-tests were performed on normalised SICI at the mid-point to determine 
whether SICI was modulated by the first train of cTBS (i.e. cTBSlow or cTBSsham). SICI 
was not significantly different from baseline (i.e. 1.00) post-cTBSlow (t(10) = 0.64, p = 














































Figure 8. MEP amplitude expressed as a percentage of baseline post-cTBS. (A) The 
time course of change in both cTBSlow (open symbol) and cTBSsham (filled symbol) 
conditions. Time-points are horizontally offset so that error bars are visible. Error bars 
represent standard error of the mean. The orange frame highlights the change in MEP 
following the first train of cTBS. (B and C) Comparison of inter-individual variability 
in responses, to both cTBSlow and cTBSsham protocols, respectively. Response profiles 
are expressed as the mean percentage change in MEP amplitude (bars below 0 reflect 
expected decrease in MEP amplitude, bars above 0 reflect increase in MEP amplitude 
post-cTBSNyffeler). The mean percentage change in MEP amplitude was determined by 
calculating the average change in MEP amplitude post-cTBSNyffeler from baseline for 
each individual. Black * = reflects that this time-point in the cTBSlow condition is 
significantly different from baseline (p < .05). Purple * reflects that this time-point in 












Figure 9. SICI expressed as a percentage of baseline post-cTBS for the two conditions. 
Depicts the time course of SICI change in both cTBSlow (open symbols) and cTBSsham 
(filled symbols) conditions. The orange frame highlights the change in SICI following 
the first train of cTBS. Time-points are horizontally offset so that error bars are visible. 
Error bars represent standard error of the mean. 
Post-cTBSNyffeler. All data points outside the orange frame in panel A of Figure 8 
show the time-course of change in MEP following cTBSNyffeler primed by either cTBSlow 
or cTBSsham. A two-way RM ANOVA was performed to determine whether the change 
in MEP amplitude post-cTBSNyffeler in the cTBSlow condition was significantly different 
than the change in MEP amplitude post-cTBSNyffeler in the cTBSsham condition. There 
was a significant main effect of PROTOCOL (F (1, 11) = 11.09, p = .01, ηp 2 = .50), and 
a main effect of TIME that approached statistical significance (F (5, 55) = 2.24, p = .06, 
ηp 2 = .17). There was no significant interaction between TIME and PROTOCOL (F (5, 
55) = 0.88, p = .50, ηp 2 = 0.07). Single-sample t-tests were performed on normalised 
MEP amplitude at all post-cTBSNyffeler time-points to determine whether MEP was 
modulated post-cTBSNyffeler in either the cTBSlow or cTBSsham condition. In the cTBSlow 
condition, there was a significant decrease in MEP amplitude from baseline (i.e. 1.00) at 
5 (t(11) = -3.67, p = .004, d = 1.07), 10 (t(11) = -2.91, p = .01, d = 0.85), and 45 (t(11) = 
-2.31, p = .04, d = 0.66) minutes post-cTBSNyffeler, and a numerical decrease in MEP that 
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approached statistical significance at 20 (t(11) = -2.08, p = .06, d = .62) and 30 (t(11) = 
-2.13, p = .06, d = 0.63) minutes post-cTBSNyffeler. In the cTBSsham condition, single-
samples t-tests showed a significant increase in MEP amplitude from baseline 
immediately post-cTBSNyffeler (t(11) = 3.83, p = .003, d = 1.10), and a numerical 
increase in MEP amplitude that approached statistical significance at 10 minutes post-
cTBSNyffeler (t(11) = 2.10, p = .06, d = 0.60). Single-sample t-tests further revealed that 
MEP amplitude did not significantly differ from baseline at the remaining time-points 
(i.e. 5, 20, 30 and 45 minutes) post-cTBSNyffeler in the cTBSsham condition (t(11) ≤ 1.38, 
p ≥ .20). Panel B of Figure 8 shows the mean change in MEP amplitude post-
cTBSNyffeler for the cTBSlow condition, and panel C of Figure 8 shows the mean change 
in MEP amplitude post-cTBSNyffeler for the cTBSsham condition. Numerically, responses 
in the cTBSsham condition were more variable than responses in the cTBSlow condition. 
In the cTBSlow condition, 91% of participants responded with overall MEP depression, 
while 27% of participants in the cTBSsham condition responded with an overall MEP 
depression.  
All data points outside of the orange frame in Figure 9 show the time-course of 
change in SICI following cTBSNyffeler primed by either cTBSlow or cTBSsham. A two-way 
RM ANOVA was performed to determine whether the change in SICI post-cTBSNyffeler 
in the cTBSlow condition was significantly different from the change in SICI post-
cTBSNyffeler in the cTBSsham condition. There were no significant main effects or 
interactions (F ≤ 3.38, p ≥ .10, ηp 2 ≤ 0.25). Single-sample t-tests were performed on 
normalised SICI at all post-cTBSNyffeler time-points to determine whether SICI was 
modulated post-cTBSNyffeler in either condition. There was a numerical increase in SICI 
from baseline (i.e. 1.00) immediately post-cTBSNyffeler in the cTBSsham condition that 
approached statistical significance (t(10) = -2.10, p = .06, d = 0.64). SICI did not 
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significantly differ from baseline at the remaining time-points post-cTBSNyffeler (i.e. 5, 
10, 20, 30, and 45 minutes) in the cTBSsham condition (t(10) ≤ 1.04, p ≥ .32), or at any 
time-point in the cTBSlow condition (t(10) ≤  1.70, p ≥ .12).  
Associations. Pearson’s r correlations were performed to determine whether a 
change in MEP amplitude immediately following the first train of cTBS was associated 
with the average change in MEP post-cTBSNyffeler in either condition. In the cTBSlow 
condition, a change in MEP amplitude post-cTBSlow was significantly related to the 
average change in MEP post-cTBSNyffeler (r(11) = .83, p = .001). Furthermore, in the 
cTBSsham condition, the relationship between MEP amplitude post-cTBSlow and the 
average change in MEP post-cTBSNyffeler approached statistical significance (r(11) = 
.56, p =.06). That is, individuals who showed a large decrease in MEP amplitude post-
cTBSlow or post-cTBSsham showed a greater depression in MEP post-cTBSNyffeler.  
Estimated AMT 
As described in Methods, the intensity for cTBSlow was set at 70% of the 
estimated AMT. At the completion of the second testing session, true AMT was 
obtained for each individual.  Figure 10 shows the stimulator intensity of cTBSlow set 
with estimated AMT (left) and the stimulator intensity of cTBSlow set with true AMT 
(right) for each participant (N = 32). Paired-samples t-tests were performed on all 38 
participants to determine whether the stimulator intensity of cTBSlow set with estimated 
AMT was significantly different from true AMT. Across all groups (including the 
unplanned group), estimated AMT was not significantly different from actual AMT 
(t(32) = 0.29, p = .77, d = 0.03). On average, AMT was 82% of RMT for participants in 
the experimental phase, which was the same as the ratio obtained from pilot data 
collection. 







Figure 10. cTBSlow stimulator intensities set with estimated AMT (left) and actual AMT 
(right). % of MSO = percentage of maximum stimulator output. Green = planned group, 
blue = planned Nyffeler group, red = unplanned group.  
Discussion 
The aim of the current study was to determine whether cTBSlow could reduce 
inhibition, and lead to more consistent neuroplasticity induction following cTBSNyffeler. 
The original design of this study incorporated one sample of participants (with a 
planned N of 30), however, due to unforeseen technical issues, the study comprised of 
three groups: planned (n = 14), in which both cTBSlow and cTBSNyffeler were applied 
with the conventional three-pulse bursts; planned Nyffeler (n = 12), in which cTBSlow 
was applied with unconventional two-pulse bursts and cTBSNyffeler was applied with 
conventional three-pulse bursts; unplanned (n = 6), in which cTBSlow and cTBSNyffeler 
were applied with unconventional two-pulse bursts. Given that there was such a small 
sample size, data analyses and interpretations of the unplanned group were not 
presented in the main text of the current study. Furthermore, due to the different 
applications of cTBS and statistically significant differences in baseline 
neurophysiological characteristics (i.e. RMT and age), no direct comparisons have been 
made between groups.  
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The results of the planned group were used to address the original hypotheses. In 
agreement with the first hypothesis, SICI significantly decreased immediately following 
cTBSlow but not cTBSsham. Secondly, it was hypothesised that there would be a greater 
decrease in MEP amplitude following cTBSNyffeler primed by cTBSlow (i.e. primed 
cTBSNyffeler), compared to cTBSNyffeler primed by cTBSsham (i.e. cTBSNyffeler alone). This 
hypothesis was not supported. Lastly, in contrast to the third hypothesis, a reduction in 
SICI following cTBSlow was not positively related to a depression in MEP amplitude 
following cTBSNyffeler. Interestingly, while MEP amplitude did not significantly change 
in the planned group, the primed cTBSNyffeler protocol in the planned Nyffeler group 
induced a long-lasting, and less-variable, MEP depression.  
Planned Group    
Current results show a decrease in SICI immediately following cTBSlow, as 
expected and consistent with McAllister et al. (2009). SICI provides a measure of 
intracortical inhibition that is mediated by GABAergic inhibition (Illic et al., 2002), the 
main inhibitory neurotransmitter in the central nervous system (Kalat, 2013). 
Pharmacological evidence suggests that SICI is mediated by a type of GABA receptor, 
GABAA (Di Lazzaro et al., 2006). Therefore, the reduction in SICI post-cTBSlow found 
in the current study likely reflects a decrease in GABAAergic inhibition (McAllister et 
al., 2009). Furthermore, there was no change in MEP amplitude following cTBSlow, 
consistent with McAllister et al. (2009). This suggests that cTBSlow selectively 
modulates the excitability of intracortical inhibitory circuits, mediated by GABAA, but 
not the excitability of intracortical excitatory circuits.  
Current results do not show a significant difference in SICI following cTBSNyffeler 
primed by cTBSlow, or following cTBSNyffeler alone. However, there was a trend of a 
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greater decrease in SICI following primed cTBSNyffeler compared to cTBSNyffeler alone. 
Following primed cTBSNyffeler, SICI was variable and lacked a significant change. 
Surprisingly, at 45 minutes post-primed cTBSNyffeler, variability in the SICI circuits was 
reduced, and there was a significant reduction in SICI relative to baseline. From these 
data, it is not possible to determine whether the decrease in SICI at 45 minutes is due to 
cTBSNyffeler, or due to a lasting decrease in SICI following cTBSlow. McAllister et al. 
(2009) showed a significant reduction in SICI between 5 and 20 minutes post-cTBSlow, 
and a numerical but not statistically significant decrease in SICI at 20 to 30 minutes 
post-cTBSlow. Future research should systematically investigate the time-course of SICI 
change following cTBSlow.  
Despite the reduction in SICI following cTBSlow, and contrary to the second 
hypothesis, primed cTBSNyffeler had no systematic effect on MEP amplitude. 
Additionally, cTBSNyffeler alone did not lead to a significant decrease in MEP amplitude. 
The absence of a change in MEP amplitude following cTBSNyffeler alone suggests that 
this protocol does not reliably induce LTD-like effects in M1. This finding contradicts 
previous research where cTBSNyffeler produced a more consistent and long-lasting 
depression in MEP amplitude compared to the Huang et al. (2005) paradigm 
(Goldsworthy et al., 2012a). It is worth noting that cTBSNyffeler has not been used a lot in 
the literature. Therefore, the data from this study are valuable and suggest that, in 
contrast to Goldsworthy et al. (2012a), the inter-individual variability in response to 
cTBSNyffeler might be comparable to the variability of the Huang et al. (2005) cTBS 
paradigm (Hamada et al., 2013). Thus, if cTBSNyffeler alone does not reliably induce 
LTD-like neuroplasticity, then applying a priming protocol that decreases inhibition 
(like cTBSlow) will not be effective at enhancing neuroplasticity induction. That is to 
say, cTBSNyffeler will not induce LTD-like effects, irrespective of the plasticity state of 
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M1. This explanation is consistent with the null finding regarding the third hypothesis, 
where the response to primed cTBSNyffeler was not associated with a changed in SICI 
following cTBSlow.  
An alternative explanation for the absence of change in MEP amplitude post-
primed cTBSNyffeler is that the interval between cTBSlow and cTBSNyffeler was sub-
optimal. The rationale for employing a 10-minute interval was two-fold: 1) the greatest 
reduction in SICI occurs between five and twenty minutes post-cTBSlow (McAllister et 
al., 2009); 2) response to cTBS is greater following two applications of cTBS spaced at 
10 minutes (Goldsworthy et al., 2012b). This rationale was limited by the lack of 
research regarding the time-course of change in SICI post-cTBSlow. However, the sub-
optimal inter-trial interval explanation would not account for both protocols failing to 
induce a significant depression of MEP amplitude, as cTBSNyffeler alone was expected to 
induce LTD-like effects. Therefore, it is more likely that cTBSNyffeler is not a reliable 
protocol for inducing LTD-like effects in M1. 
It is worth noting that, Murakami et al. (2012) examined the priming effect of 
cTBSlow on cTBS and, although the cTBS paradigm was different (i.e. Huang et al., 
2005), there was no change in MEP amplitude (Murakami et al., 2012). When the 
present study and the Murakami et al. (2012) study are taken together, these results 
suggests that down-regulating intracortical inhibition with cTBSlow might not make M1 
more amenable to neuroplasticity induction. However, with highly variable test 
protocols, and a lack of knowledge regarding the time-course of change in SICI post-
cTBSlow, it is not currently possible to conclude whether the null finding is a true effect.    
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Planned Nyffeler Group  
In the planned Nyffeler group, a significant decrease in MEP amplitude was found 
following two-burst cTBSlow, but not two-burst cTBSsham. This result was further 
supported by preliminary data analyses of the unplanned group (which received the 
same two-burst cTBSlow priming stimulation; see Appendix F for preliminary data 
analyses and interpretations of the unplanned group). This result suggests that two-burst 
cTBSlow suppressed corticospinal excitability. Additionally, SICI did not change 
significantly from baseline in either the two-burst cTBSlow or two-burst cTBSsham 
conditions. This suggests that the suppression of corticospinal excitability induced by 
two-burst cTBSlow was not driven by a change in GABAA-mediated inhibition. 
However, the two-burst protocol was unplanned, and with no previous research on two-
burst cTBS, it is difficult to interpret these results.  
A highly speculative interpretation of these data stems from a recent TMS-EEG 
study (Premoli et al., 2014). Combined TMS-EEG allows measurement of electrical 
activity from the scalp, in response to TMS (Premoli et al., 2014). TMS-EEG measures 
waveforms known as TMS-evoked potentials (TEPs), which have both inhibitory and 
excitatory components (Premoli et al., 2014). Premoli et al. (2014) revealed that there is 
an inhibitory component at a 45ms post-TMS. The latency of this process is similar to 
the timing of two-burst cTBSlow intra-burst stimuli (i.e. 40ms). The inhibitory 
component at 45ms is thought to be mediated by the inhibitory circuits of another type 
of GABA receptor, GABAB (Premoli et al., 2014). Therefore, a speculative 
interpretation of the effect of two-burst cTBSlow would be that this protocol might have 
influenced the excitability of inhibitory processes, that were preferentially active at 
around 40ms, which led to a net reduction in corticospinal excitability. To better 
understand the mechanisms underlying this change, further research should investigate 
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the effect of two-burst cTBSlow with combined TMS-EEG. To investigate this, TEPs 
would be measured before and after the application of two-burst cTBSlow and two-burst 
cTBSsham (at several time points). If two-burst cTBSlow does excite this particular 
inhibitory process, which can be measured by the size of the peak at 45ms, it would be 
expected that the peak of this component would be larger after two-burst cTBSlow 
compared to two-burst cTBSsham (see Figure 11 for an illustration of the expected 
change in TEP following two-burst cTBSlow).  
Figure 11. Expected change in TMS-evoked potential following two-burst cTBSlow. 
N45 = inhibitory component that occurs 45ms following a suprathreshold TMS pulse. 
Vertical dashed lines indicated the time of the suprathreshold TMS pulse.  
Additionally, in the planned Nyffeler group, cTBSNyffeler primed by two-pulse 
cTBSlow led to greater, longer-lasting, and less-variable MEP depression than 
cTBSNyffeler alone. This result suggests that the two-burst cTBSlow primed cTBSNyffeler 
protocol suppresses corticospinal excitability. Furthermore, SICI did not significantly 
change following two-burst cTBSlow or two-burst cTBSlow-primed cTBSNyffeler. This 
suggests that it is unlikely that depression in corticospinal excitability was driven by a 
change in GABAAergic inhibition. Furthermore, there was a positive linear relationship 
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between a change in MEP amplitude following two-burst cTBSlow and the average 
change in MEP amplitude post-primed-cTBSNyffeler. This might suggest that a long-
lasting LTD-like effect, driven by two-burst cBTSlow, might be mediating the decrease 
in corticospinal excitability following cTBSNyffeler However, this explanation is 
speculative and cannot be concluded from these data.  
Alternatively, the two-burst cTBSlow paradigm might have primed cTBSNyffeler to 
induce longer-lasting depression in corticospinal excitability through spaced cTBS-like 
mechanisms. Similar to the protocol in this study, spaced-cTBS involves the application 
of two trains of cTBS (following the Huang et al., 2005 paradigm), at an inter-train 
interval of 10 minutes (Goldsworthy et al., 2012b). Spaced-cTBS has been shown to 
lead to longer-lasting depression in corticospinal excitability relative to a single train of 
cTBS (Goldsworthy et al., 2012b). Goldsworthy et al. (2012b) suggested that the 
increased efficacy of spaced-cTBS was the result of an accumulative effect, whereby 
applying a greater number of pulses led to longer-lasting depression of corticospinal 
excitability. While the stimulation parameters of spaced-cTBS used by Goldsworthy et 
al. (2012b) are slightly different from the parameters of cTBSlow primed cTBSNyffeler 
used here, it is possible that the depression in corticospinal excitability observed in the 
current study occurred through similar mechanisms.  
While the mechanisms underlying the observed change in corticospinal 
excitability are unknown, the findings of the current study suggest that the two-burst 
cTBSlow paradigm could potentially contribute to the development of a consistent 
plasticity-inducing cTBS protocol. It is possible that two-burst cTBSlow has a lasting 
effect on corticospinal excitability, however, this needs to be tested systematically. 
Therefore, future research, with a more powerful sample, is required to fully 
characterise the change in MEP amplitude following two-burst cTBSlow and determine 
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whether this paradigm can reliably induce LTD-like plasticity. To investigate this, MEP 
amplitude would be measured before and after the application of two-burst cTBSlow and 
two-burst cTBSsham (at several time points). 
In addition to MEP depression in the cTBSlow condition, there were two time-
points in the cTBSsham condition where MEP amplitude was significantly facilitated 
(specifically, at 0 and 10 minutes post-cTBSNyffeler). Given the lack of MEP facilitation 
post-cTBSNyffeler alone in the planned group, it is unclear as to whether this is a true 
facilitation or noise from inter-individual variability. It is worth noting that Hamada et 
al. (2013) found that 42% of participants showed the expected decrease in MEP 
amplitude to the cTBS Huang et al. (2005) paradigm, and 58% showed an increase in 
MEP amplitude. It is speculated that there may be a similar proportion of individuals 
showing expected and unexpected responses to cTBSNyffeler alone. Future research with 
a more powerful sample is required to determine whether cTBSNyffeler alone induces an 
increase in MEP.  
It is important to note that there was a significant difference in RMT between 
sessions in this group. Previous research has demonstrated that the RMT of individuals 
is subject to a small and unsystematic amount of change between sessions (Hermsen et 
al., 2016). In light of this research, it was unlikely that the small but significant 
difference in RMT in the current study was systematic. If this was a chance finding, 
then the 1.67% difference in average RMTRapid between conditions was unlikely to have 
affected the results. Nonetheless, the presented results and interpretations should be 
considered with caution.  
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Estimated AMT  
McAllister et al. (2009) set the stimulator intensity for cTBSlow relative to each 
individual’s actual AMT. However, actual AMT requires sustaining a voluntary 
contraction prior to cTBS, which has been shown to reduce the neuroplastic response of 
cTBS (Huang et al., 2008). Therefore, to eliminate the potential effect of contraction on 
the cTBS response in the current study, the intensity of cTBSlow was set by estimating 
AMT from each individual’s RMT. When the pilot and experimental data were 
compared, the ratio of AMT to RMT was exactly the same, which suggests that at the 
group level this formula was an accurate and reliable method for estimating AMT. 
Thus, the above results were not likely affected by using a formula to estimating the 
intensity of cTBSlow. While the formula was accurate at the group level, AMT would 
have been under- or over-estimated at the individual level. This might have had an 
influence on the cTBSlow stimulator intensity at the individual level. While the 
difference between estimated and true AMT could be added as a covariate in analyses, 
the current study was not sufficiently powered for this analysis. Therefore, this study 
could not determine the influence of variability in estimated AMT on cTBS-induced 
neuroplasticity.  
Limitations, Clinical Implications, and Future Research  
It is important to note that the findings of the current study may have been limited 
by the influence of intra-individual variability on neuroplasticity-induction. Intra-
individual variability refers to factors within the individual that vary on a day-to-day (or 
more frequent) basis (e.g. stress hormone levels; Sale, Ridding, & Nordstrom, 2008). 
There is evidence that neuroplasticity-inducing NIBS protocols are influenced, and thus 
limited by, intra-individual variability (Vallence et al., 2015). This limitation can be 
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overcome in future research by applying the same protocol to individuals over multiple 
sessions.  
Nonetheless, the current results make a valuable contribution to the understanding of 
non-invasive brain stimulation-induced (NIBS-induced) neuroplasticity. The results do, 
however, confirm the current view in the literature that NIBS-induced neuroplasticity is 
variable. Even so, NIBS is already used widely in clinical settings, therefore it is 
important to continue better understand it. Specifically, it is clinically important to 
identify methods for optimising the way neuroplasticity is induced in conscious 
humans. An approach to optimising neuroplasticity induction is through NIBS priming. 
Although the efficacy of priming in the current study is unclear, incorporating primers 
in NIBS protocols is a promising method for reliable M1 neuroplasticity induction 
(Ridding & Ziemann, 2010). For example, a NIBS technique that delivers low current 
electrical stimulation (known as tDCS), has been effectively used to prime motor 
learning (Christova, Rafolt, & Gallasch, 2015). Therefore, with promising effects in 
inducing functionally relevant neuroplasticity, it is worth continuing to investigate 
priming as a method of optimising neuroplasticity-induction. 
Conclusion  
The current study offers three important findings. First, when three-burst cTBSlow 
was applied to M1, intracortical inhibition in the stimulated brain region was down-
regulated. This replicated the findings of previous research (McAllister et al., 2009). 
However, the current results also suggest that this reduction in intracortical inhibition 
has no effect on neuroplasticity-induction following cTBSNyffeler. Second, unexpected 
technical issues in data collection led to preliminary evidence for a cTBS-protocol that 
consistently reduces MEP amplitude (that is, two-burst cTBSlow). It is recommended 
EFFICACY OF NON-INVASIVE BRAIN STIMULATION 51 
that the effect of two-burst cTBSlow continue to be investigated in a larger sample of 
healthy populations, with more complex methods (e.g. combined TMS-EEG). Third, the 
unexpected protocol that reduced MEP amplitude (i.e. two-burst cTBSlow) was also 
associated with long-lasting and less-variable neuroplasticity-induction following a test-
cTBS protocol (i.e. three-burst cTBSNyffeler). Taken together, the current findings offer 
evidence that non-invasive brain stimulation techniques can induce neuroplastic 
responses, and therefore offer promise for the therapeutic application of these 
techniques.  
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